Patricia Cornet, Bristol-Myers Squibb, Named to HOSA-100 National Advisory Council

Patricia Cornet, Director Global Scientific Societies and Cooperative Groups, Global Medical Oncology, Bristol-Myers Squibb, and Co-founder & Vice President of Women of Color in Pharma (WOCIP), has joined the HOSA-100 National Advisory Council.

HOSA is honored to have a person with the many talents that Pat possesses serving on the HOSA-100 National Advisory Council.   Pat is passionate about delivering health focused solutions to ensure access to innovative treatments to patients and advancing the careers of women and development of young girls. She has over fifteen years of experience in

the pharmaceutical industry and is the Co-Founder and Vice President of Women of Color in Pharma (WOCIP).  During her tenure in the pharmaceutical industry, she has managed complex therapeutic portfolios across multiple disease areas and lead matrix-based projects while ensuring effective collaboration across functions including medical, clinical and commercial.

She most recently developed global strategic partnerships and patient engagement models through collaboration with societies, advocacy groups, diversity-focused organizations andphysician communities.

Pat joined BMS in 2004 as Protocol Manager in Central Clinical Operations and later assumed the role of Senior Recruitment Manager – Shanghai, China. In this role, she supported the overall goal of building the clinical trial business in the geographic region by focusing on patient engagement, development of investigational sites, and leveraging collaborations with Market Access and Commercial to support the research portfolio in Oncology, Immunology, Virology, Diabetes and Cardiovascular (CV) diseases. In 2009 she returned to the U.S. to oversee a global team of recruitment managers and country specialist. As Associate Director for the team, Pat was responsible for driving the strategic direction of the recruitment team and department initiatives for early phase and late phase studies. In 2013 she moved into the role of Strategic Lead Diversity & Patient Engagement, Specialty in the Global Development Operations (GDO)organization. Here, she focused on developing partnerships with advocacy organizations and professional societies to bring the patient voice into the clinical development process and to drive greater accessibility, awareness and education of clinical trials across the GDO portfolio as well as ensuring diversity in trial participation. She later joined the Commercial Organization as the Global Policy and Advocacy Lead Rare and CV disease, responsible for managing initiatives and external relations to accelerate in-pipeline asset development and to enhancing education, awareness and access to patients for our marketed product indications in CV.

Prior to joining BMS, Pat held the position of Clinical Research Associate for Bio Pharm Clinical Services and later joined Merck (Schering-Plough Research Institute) where she held positions in Clinical Research, Medical Planning (US Medical) and in Global Development Operations and Clinical Operations & Resource Management. She began her career in research at the National Disease Research Interchange, conducting genetic research projects in families with children having type 1 diabetes.

She is also an advocate and proponent for diversity and inclusion in the work place as well as in our society. In 2015, Pat and Co-Founder Dr. Charlotte Jones-Burton, established an informal network to address gaps for women of color in the pharmaceutical industry. The informal network has grown from a group of 30 to over 300 with presence on Facebook, LinkedIn and other digital channels. At the end of 2016, the organization was formalized into a non-profit entity and will transition into a professional society at its launch in November 2017. The vision of this organization is to transform the pharmaceutical landscape for women of color; breaking through the hurdles enabling personal and professional growth. At BMS, Pat is actively involved in the Business Employee Resource Groups, Black Organization for Leadership Development (BOLD) and Bristol-Myers Squibb Network of Women (BNOW) diversity programs that support the Global Diversity & Inclusion goals of the company.

Pat received her B.A. in Biology from Arcadia University, Glenside, PA and her M.A. Human Services Administration from Rider University, Lawrenceville, NJ.  Pat is also a mother, novice runner, cellist and a leader in various non-profit organizations focused on the advancement of women and young girls.  She is especially proud of her daughter, Annelise, who has been a member of the Princeton Girlchoir for four years and is currently attending The Pennington School.

HOSA appreciates the opportunity to work with Ms. Cornet, and we look forward to finding ways to support educational and awareness efforts that will support both Bristol Myers Squibb and HOSA-Future Health Professionals.

About Bristol-Myers Squibb:  Bristol-Myers Squibb (BMS), headquartered in New York City, is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients.  Some prescription pharmaceuticals BMS manufactures are in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders to name a few.